Financial Performance

Cabana's latest acquisition is more than just expansion; it's a tech-driven strategy to professionalize a $10B industry, one local legacy at a time.

Encore celebrates its global 'Great Place To Work' award. We look past the press release to see if these certifications are just PR or a real driver of growth.

Amid data overload and budget cuts, Cision's new AI tool promises to decode media coverage into actionable strategy. But can it truly solve PR's dilemma?

While the AI boom creates a global memory chip shortage, one company's proactive strategy offers a powerful lesson in how foresight and control build stability.

Oligo Security is leveraging Palantir's FedStart to slash federal compliance timelines, arming agencies with real-time defense against AI-assisted attacks.

Why does a vet visit cost so much? We dissect the complex factors driving prices, from diagnostics to overhead, and reveal how to manage your pet's health budget.

The K-beauty giant's massive Amazon sale is more than just discounts; it's a strategic play to launch products, capture new markets, and solidify its e-commerce dominance.

With $4.6M in funding, a San Diego startup is challenging the multi-million dollar surgical robotics market with a handheld, AI-powered device.

In a column dedicated to high-tech disruption, we explore a different kind of innovation: a law firm building a house, proving that some of the best returns still come from hammers, not code.

With drilling at its massive Wyoming project and new exploration in Arizona and Nevada, ARR is executing a multi-front strategy to build a domestic supply chain.

A landmark deal for Eos's zinc battery tech, backed by Cerberus capital, aims to solve Texas's grid woes and prove a new model for energy storage finance.

Richtech Robotics' new 24/7 livestream isn't just a gimmick. It's a look at the digital backbone—from NVIDIA chips to AI grids—powering our future.

Cabot Corporation's sixth EcoVadis Platinum rating is more than an award; it highlights a crucial evolution in corporate accountability, ethics, and trust.

Quoin Pharma is making a bold bet, building a full commercial operation in Japan for its rare disease drug years before a potential launch. Is this the new model?

New data reveals a 'Women CEO Effect'—companies led by women don't just break ceilings, they build entirely new pipelines for female leadership.

SRx Health Solutions rebrands as SRX Global after acquiring a crypto AI firm. But with a history of pivots and a 35% stock drop, is this a brilliant rebirth or a desperate gamble?

Nuwellis bets on educating hundreds of physicians on its Aquadex system, a high-stakes strategy to combat fluid overload and secure its place in medicine.

The gas shipping giant just secured $206 million for new vessels, but the real story isn't the money—it's the sophisticated financial tool they used.

Aether Holdings launches Alphid, an AI platform connecting to brokerage accounts. Is this the key to leveling the playing field for retail investors, or a new risk?

Silo Pharma has navigated a critical headwind, regaining Nasdaq compliance. This move provides vital stability, allowing the firm to focus on its true test.